Fundamentals data is not available for this company.
| Gilead Sciences to buy Immunomedics in $21bn deal | 14-Sep-2020 | ShareCast |
| Currency | US Dollars |
| Share Price | $ 0.00 |
| Closing Price Change | $ 0.00 |
| % Change | 0.00 % |
| 52 Week High | $0.00 |
| 52 Week Low | $0.00 |
| Volume | 0 |
| Shares Issued | 186.83m |
| RiskGrade | 538 |
You are here: research